Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed...
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy
About this item
Full title
Author / Creator
Georgi, Thomas Walter , Kurch, Lars , Franke, Georg-Nikolaus , Jentzsch, Madlen , Schwind, Sebastian , Perez-Fernandez, Carmen , Petermann, Naima , Merz, Maximilian , Metzeler, Klaus , Borte, Gudrun , Hoffmann, Sandra , Herling, Marco , Denecke, Timm , Kluge, Regine , Sabri, Osama , Platzbecker, Uwe and Vučinić, Vladan
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
Chimeric antigen receptor (CAR)-T cells are a viable treatment option for patients with relapsed or refractory (r/r) aggressive B-cell lymphomas. The prognosis of patients who relapse after CAR-T cell treatment is dismal and factors predicting outcomes need to be identified. Our aim was to assess the value of FDG-PET/CT in terms of predi...
Alternative Titles
Full title
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10356653
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10356653
Other Identifiers
ISSN
0171-5216
E-ISSN
1432-1335
DOI
10.1007/s00432-023-04587-4
